{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:46Z","timestamp":1786123246810,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1213\/ane.0b013e3182075d04","type":"journal-article","created":{"date-parts":[[2011,1,15]],"date-time":"2011-01-15T01:10:49Z","timestamp":1295053849000},"page":"655-660","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacokinetics of Single-Dose Intravenous Ketorolac in Infants Aged 2\u201311 Months"],"prefix":"10.1213","volume":"112","author":[{"given":"Mindy N.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Henthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zung","family":"Vu Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Zuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Galinkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20210902","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2044.1987.tb05317.x","article-title":"The morphine sparing effect of ketorolac tromethamine: a study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery.","volume":"42","author":"Gillies","year":"1987","journal-title":"Anaesthesia"},{"key":"R2-30-20210902","first-page":"14","article-title":"The nonsteroidal anti-inflammatory analgesics.","volume":"26","author":"Power","year":"1989","journal-title":"NATNEWS"},{"key":"R3-30-20210902","first-page":"479","article-title":"The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt.","volume":"11","author":"Rooks","year":"1985","journal-title":"Drugs Exp Clin Res"},{"key":"R4-30-20210902","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00558243","article-title":"The effects on ventilation of ketorolac in comparison with morphine.","volume":"35","author":"Bravo","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"R5-30-20210902","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/bja\/63.5.601","article-title":"Comparison of the cardiorespiratory effects of ketorolac and alfentanil during propofol anaesthesia.","volume":"63","author":"Murray","year":"1989","journal-title":"Br J Anaesth"},{"key":"R6-30-20210902","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1002\/j.1875-9114.1990.tb03588.x","article-title":"Comparison of intravenous ketorolac tromethamine and morphine sulfate in the treatment of postoperative pain.","volume":"10","author":"Brown","year":"1990","journal-title":"Pharmacotherapy"},{"key":"R7-30-20210902","doi-asserted-by":"crossref","first-page":"111S","DOI":"10.1002\/j.1875-9114.1990.tb03587.x","article-title":"Intravenous ketorolac tromethamine versus morphine sulfate in the treatment of immediate postoperative pain.","volume":"10","author":"Peirce","year":"1990","journal-title":"Pharmacotherapy"},{"key":"R9-30-20210902","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0952-8180(95)00058-P","article-title":"Use of analgesics during propofol sedation: a comparison of ketorolac, dezocine, and fentanyl.","volume":"7","author":"Ramirez-Ruiz","year":"1995","journal-title":"J Clin Anesth"},{"key":"R10-30-20210902","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1002\/j.1875-9114.1990.tb03578.x","article-title":"Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.","volume":"10","author":"Mroszczak","year":"1990","journal-title":"Pharmacotherapy"},{"key":"R11-30-20210902","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1034\/j.1399-6576.1999.431012.x","article-title":"Stereoselective pharmacokinetics of ketorolac in children, adolescents and adults.","volume":"43","author":"Hamunen","year":"1999","journal-title":"Acta Anaesthesiol Scand"},{"key":"R12-30-20210902","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0009-9236(99)70131-1","article-title":"Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.","volume":"65","author":"Kauffman","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"R13-30-20210902","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1213\/01.ane.0000260320.60867.6c","article-title":"Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics.","volume":"104","author":"Lynn","year":"2007","journal-title":"Anesth Analg"},{"key":"R14-30-20210902","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00561376","article-title":"Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.","volume":"35","author":"Jung","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"R15-30-20210902","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2125.1991.tb05510.x","article-title":"The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children.","volume":"31","author":"Olkkola","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"R16-30-20210902","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1213\/00000539-200202000-00007","article-title":"Age-stratified pharmacokinetics of ketorolac tromethamine in pediatric surgical patients.","volume":"94","author":"Dsida","year":"2002","journal-title":"Anesth Analg"},{"key":"R17-30-20210902","first-page":"160","article-title":"Pharmacokinetics of ketorolac in children after abdominal surgery.","volume":"35","author":"Gonzalez-Martin","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R18-30-20210902","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MJT.0b013e31818071df","article-title":"Population pharmacokinetics of ketorolac in neonates and young infants.","volume":"16","author":"Zuppa","year":"2009","journal-title":"Am J Ther"},{"key":"R19-30-20210902","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0090-9556(25)06795-9","article-title":"Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.","volume":"15","author":"Mroszczak","year":"1987","journal-title":"Drug Metab Dispos"},{"key":"R20-30-20210902","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1023\/A:1015803803650","article-title":"Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine.","volume":"6","author":"Jung","year":"1989","journal-title":"Pharm Res"},{"key":"R21-30-20210902","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/j.1552-4604.1990.tb03442.x","article-title":"Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly.","volume":"30","author":"Jallad","year":"1990","journal-title":"J Clin Pharmacol"},{"key":"R22-30-20210902","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1460-9592.2003.00959.x","article-title":"Ventilatory effects of morphine infusions in cyanotic versus acyanotic infants after thoracotomy.","volume":"13","author":"Lynn","year":"2003","journal-title":"Paediatr Anaesth"},{"key":"R23-30-20210902","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.jchromb.2009.08.020","article-title":"Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography-tandem mass spectrometry.","volume":"877","author":"Clavijo","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R24-30-20210902","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2008.08.021","article-title":"An automated, highly sensitive LC-MSMS assay for the quantification of the opiate antagonist naltrexone and its major metabolite 6beta-naltrexol in dog and human plasma.","volume":"874","author":"Clavijo","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R25-30-20210902","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1570-0232(02)00142-3","article-title":"Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries.","volume":"773","author":"Muller","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R26-30-20210902","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4899-1959-5_5","article-title":"Compartmental models: theory and practice using the SAAM II software system.","volume":"445","author":"Cobelli","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"R27-30-20210902","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4899-1959-5_4","article-title":"Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system.","volume":"445","author":"Foster","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"R28-30-20210902","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0009-9236(96)90210-6","article-title":"Population pharmacodynamic model for ketorolac analgesia.","volume":"60","author":"Mandema","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"R29-30-20210902","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7326\/0003-4819-126-3-199702010-00003","article-title":"Parenteral ketorolac: the risk for acute renal failure.","volume":"126","author":"Feldman","year":"1997","journal-title":"Ann Intern Med"},{"key":"R30-30-20210902","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0009922806292813","article-title":"Acute renal failure.","volume":"45","author":"Kallanagowdar","year":"2006","journal-title":"Clin Pediatr (Phila)"},{"key":"R31-30-20210902","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1542\/peds.98.2.294","article-title":"Ketorolac-induced acute renal failure in a previously healthy adolescent.","volume":"98","author":"Buck","year":"1996","journal-title":"Pediatrics"},{"key":"R32-30-20210902","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004670050565","article-title":"Ketorolac-induced irreversible renal failure in sickle cell disease: a case report.","volume":"13","author":"Simckes","year":"1999","journal-title":"Pediatr Nephrol"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3182075d04","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:12:28Z","timestamp":1786111948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201103000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3182075d04","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}